Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system

Fig. 2

Progression-free survival (PFS) and overall survival (OS) of patients with PCNS-DLBCL according to MYC or BCL2 expression status. a and b PFS and OS according to MYC protein expression status (cutoff score 40) are plotted using the Kaplan-Meier method and analyzed by the log-rank test. PFS and OS according to BCL2 protein expression status using a cutoff score of 30 (c and d), or with a cutoff score of 60 (e and f) are plotted using the Kaplan-Meier method and analyzed by the log-rank test

Back to article page